COMP <GO>
HNGE vs AAPL // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Hinge Health Inc. (NYSE) VS. Apple Inc. (NASDAQ) • 15-METRIC TALLY: HNGE 5
— AAPL 9
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: AAPL
LAST: $114.32 (-2.21%) • MKT CAP: $9.43B
options-implied-move
7.70%
LAST: $344.63 (-1.23%) • MKT CAP: $5.03T
options-implied-move
5.76%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HNGE VS. AAPL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HNGE | AAPL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.60% | 48.65% | +30.95 | HNGE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 81.38% | -116.38 | AAPL | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.81% | 2.72% | -0.91 | AAPL | /fcf-yield <GO> |
| Operating Margin | -60.00% | 33.17% | -93.17 | AAPL | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 27.62% | -87.62 | AAPL | /net-margins <GO> |
| Revenue Growth (YoY) | 50.60% | 14.24% | +36.36 | HNGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.31% | -0.31 | AAPL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.12 | 13.54 | -1.42 | AAPL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | AAPL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.70% | 5.76% | +1.94 | AAPL | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.5 | 55.4 | +12.15 | HNGE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.24 | 1.14 | +0.10 | HNGE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 35.3x | -6.34 | HNGE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.43B | $5.03T | -$5.02T | AAPL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HNGE REV | AAPL REV | HNGE GROSS % | AAPL GROSS % | HNGE FCF | AAPL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $587.9M | $416.16B | 79.6% | 46.9% | $170.7M | $98.77B |
| FY 2024 | $390.4M | $391.04B | 76.8% | 46.2% | $48.0M | $108.81B |
| FY 2023 | $292.7M | $383.29B | 44.0% | 44.1% | -$77.1M | $99.58B |
| FY 2022 | — | $394.33B | — | 43.3% | — | $111.44B |
| FY 2021 | — | $365.82B | — | 41.8% | — | $92.95B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HNGE // BETA 1.24
AAPL // BETA 1.14